MétaCan
Menu
Back to cohort
Record W3159281624 · doi:10.14288/1.0396710

What patient, clinician, policy and socio-cultural factors are associated with the rise in off-label prescribing of domperidone in British Columbia when used to treat low milk supply?

2021· article· en· W3159281624 on OpenAlexaboutno aff
Janet C. Currie

Bibliographic record

VenuecIRcle (University of British Columbia) · 2021
Typearticle
Languageen
FieldMedicine
TopicPharmaceutical studies and practices
Canadian institutionsnot available
Fundersnot available
KeywordsDomperidoneMedicineBusinessFamily medicinePsychology

Abstract

fetched live from OpenAlex

This research used a case study approach to study the off-label use of domperidone when it is used to treat low breastmilk supply (LMS) in British Columbia (BC). Off-label prescribing occurs when an approved drug is prescribed for a use for which it has not been approved. Off-label prescribing is prevalent in Canada and many drugs prescribed off-label lack strong evidence of effectiveness. My research objective was to identify the clinician, patient, socio-cultural and policy factors that are contributing to domperidone’s increasing use among breastfeeding mothers in BC. Results from my research were intended to increase the overall understanding of contributors to off-label prescribing in general in order to improve its transparency, safety and effectiveness. My four methodologies included online surveys with BC midwives and family physicians, interviews with breastfeeding mothers who had used domperidone to increase their breastmilk supply and an analysis of Health Canada’s policy response to off-label prescribing. The conceptual framework for the research was a socio-ecological model incorporating patient, clinician, community/institutional, socio-cultural and policy levels of analysis. I concluded that multiple factors at all of these levels have contributed to the rise in the off-label prescribing of domperidone to treat LMS in BC. Main drivers included clinician prescribing practices, knowledge and views of domperidone, patient needs and beliefs and the medicalization of breastfeeding. Policy-related factors appeared to have significant influence on off-label prescribing. Health Canada does not explicitly consider potential off-label uses in drug approval documents such as product monographs nor does it systematically collect and analyse adverse drug reactions from off-label uses to identify safety concerns. Off-label uses with safety concerns are not included in post-market surveillance activities such as Health Canada safety warnings for healthcare providers and the public. I concluded that when a drug is considered for an off-label use it should be subjected to additional scrutiny by prescribers to determine its real need and risk/benefit balance. Health Canada should systematically include off-label uses in all ADR reporting and analysis so that safety issues can be identified and responded to through post-market surveillance activities.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.016
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.146
Threshold uncertainty score0.294

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.016
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.003
Science and technology studies0.0040.002
Scholarly communication0.0040.001
Open science0.0010.002
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.036
GPT teacher head0.264
Teacher spread0.229 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2021
Admission routes1
Has abstractyes

Explore more

Same venuecIRcle (University of British Columbia)Same topicPharmaceutical studies and practicesFrench-language works237,207